

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to nitric oxide (GO:0071732) | 7.45408691 |
| 2 | negative regulation of complement activation (GO:0045916) | 7.34183414 |
| 3 | positive regulation of endothelial cell differentiation (GO:0045603) | 6.63628062 |
| 4 | negative regulation of protein activation cascade (GO:2000258) | 6.58212713 |
| 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 6.57174349 |
| 6 | response to xenobiotic stimulus (GO:0009410) | 6.41941753 |
| 7 | negative regulation of humoral immune response (GO:0002921) | 6.07878687 |
| 8 | regulation of endothelial cell differentiation (GO:0045601) | 6.05688907 |
| 9 | cellular response to reactive nitrogen species (GO:1902170) | 5.79493770 |
| 10 | lung lobe morphogenesis (GO:0060463) | 5.63076763 |
| 11 | endothelial tube morphogenesis (GO:0061154) | 5.58583333 |
| 12 | morphogenesis of an endothelium (GO:0003159) | 5.58583333 |
| 13 | response to nitric oxide (GO:0071731) | 5.51613050 |
| 14 | regulation of vasculogenesis (GO:2001212) | 5.18823040 |
| 15 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 5.04458324 |
| 16 | blood vessel maturation (GO:0001955) | 4.94718780 |
| 17 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 4.87418650 |
| 18 | pattern specification involved in kidney development (GO:0061004) | 4.83098358 |
| 19 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 4.77834266 |
| 20 | phosphate ion transmembrane transport (GO:0035435) | 4.41414834 |
| 21 | peptide catabolic process (GO:0043171) | 4.40320703 |
| 22 | lymphangiogenesis (GO:0001946) | 4.34078839 |
| 23 | induction of positive chemotaxis (GO:0050930) | 4.20851050 |
| 24 | lung vasculature development (GO:0060426) | 4.18776169 |
| 25 | trivalent inorganic anion homeostasis (GO:0072506) | 4.18494614 |
| 26 | phosphate ion homeostasis (GO:0055062) | 4.18494614 |
| 27 | positive regulation of vasculogenesis (GO:2001214) | 4.09482881 |
| 28 | one-carbon compound transport (GO:0019755) | 4.05711680 |
| 29 | establishment of apical/basal cell polarity (GO:0035089) | 4.03758559 |
| 30 | regulation of complement activation (GO:0030449) | 3.95267098 |
| 31 | mesodermal cell differentiation (GO:0048333) | 3.94419678 |
| 32 | cellular anion homeostasis (GO:0030002) | 3.91263702 |
| 33 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.89074897 |
| 34 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.86353548 |
| 35 | sodium-independent organic anion transport (GO:0043252) | 3.85917832 |
| 36 | sodium ion homeostasis (GO:0055078) | 3.84428836 |
| 37 | cellular hyperosmotic response (GO:0071474) | 3.83302613 |
| 38 | respiratory tube development (GO:0030323) | 3.80060607 |
| 39 | virion attachment to host cell (GO:0019062) | 3.78146389 |
| 40 | adhesion of symbiont to host cell (GO:0044650) | 3.78146389 |
| 41 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.71928831 |
| 42 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 3.71007181 |
| 43 | regulation of protein activation cascade (GO:2000257) | 3.65064713 |
| 44 | regulation of interleukin-13 production (GO:0032656) | 3.63162907 |
| 45 | endocrine hormone secretion (GO:0060986) | 3.62935315 |
| 46 | artery development (GO:0060840) | 3.61508720 |
| 47 | hyperosmotic salinity response (GO:0042538) | 3.61162594 |
| 48 | phosphate ion transport (GO:0006817) | 3.58335826 |
| 49 | lung alveolus development (GO:0048286) | 3.54362137 |
| 50 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.47708746 |
| 51 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.47242273 |
| 52 | establishment of monopolar cell polarity (GO:0061162) | 3.45030962 |
| 53 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.45030962 |
| 54 | regulation of hippo signaling (GO:0035330) | 3.44912397 |
| 55 | macrophage chemotaxis (GO:0048246) | 3.40836449 |
| 56 | response to vitamin A (GO:0033189) | 3.40037615 |
| 57 | iron ion import (GO:0097286) | 3.39556611 |
| 58 | endocardial cushion development (GO:0003197) | 3.38849403 |
| 59 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.38839701 |
| 60 | * respiratory gaseous exchange (GO:0007585) | 3.38785297 |
| 61 | cellular response to antibiotic (GO:0071236) | 3.31432454 |
| 62 | response to hyperoxia (GO:0055093) | 3.31281880 |
| 63 | response to increased oxygen levels (GO:0036296) | 3.31281880 |
| 64 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.30129512 |
| 65 | negative regulation of interleukin-2 production (GO:0032703) | 3.30129414 |
| 66 | complement activation (GO:0006956) | 3.30125652 |
| 67 | icosanoid transport (GO:0071715) | 3.30078216 |
| 68 | fatty acid derivative transport (GO:1901571) | 3.30078216 |
| 69 | complement activation, classical pathway (GO:0006958) | 3.29621688 |
| 70 | regulation of glomerular filtration (GO:0003093) | 3.27180218 |
| 71 | renal absorption (GO:0070293) | 3.26723740 |
| 72 | protein localization to endosome (GO:0036010) | 3.26139187 |
| 73 | hormone catabolic process (GO:0042447) | 3.24611650 |
| 74 | endothelial cell differentiation (GO:0045446) | 3.21989723 |
| 75 | cell adhesion mediated by integrin (GO:0033627) | 3.20116536 |
| 76 | adhesion of symbiont to host (GO:0044406) | 3.19576423 |
| 77 | response to interleukin-6 (GO:0070741) | 3.19468055 |
| 78 | lung secretory cell differentiation (GO:0061140) | 3.18883829 |
| 79 | norepinephrine metabolic process (GO:0042415) | 3.16675025 |
| 80 | embryonic foregut morphogenesis (GO:0048617) | 3.10218362 |
| 81 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.08263696 |
| 82 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.08248497 |
| 83 | renal filtration (GO:0097205) | 3.08047758 |
| 84 | toxin metabolic process (GO:0009404) | 3.06542151 |
| 85 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.05019525 |
| 86 | polarized epithelial cell differentiation (GO:0030859) | 3.04867139 |
| 87 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.02519607 |
| 88 | sphingosine metabolic process (GO:0006670) | 3.01774930 |
| 89 | positive regulation of p38MAPK cascade (GO:1900745) | 2.99926986 |
| 90 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.99781707 |
| 91 | ethanol oxidation (GO:0006069) | 2.98060990 |
| 92 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.97916301 |
| 93 | hemidesmosome assembly (GO:0031581) | 2.96162133 |
| 94 | wound healing, spreading of epidermal cells (GO:0035313) | 2.95695821 |
| 95 | lymph vessel development (GO:0001945) | 2.93942118 |
| 96 | positive regulation of digestive system process (GO:0060456) | 2.93766920 |
| 97 | membrane raft organization (GO:0031579) | 2.92935223 |
| 98 | endothelial cell chemotaxis (GO:0035767) | 2.92250021 |
| 99 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.89043089 |
| 100 | blood vessel remodeling (GO:0001974) | 2.87011943 |
| 101 | glomerular epithelial cell development (GO:0072310) | 2.85996734 |
| 102 | neuron remodeling (GO:0016322) | 2.85517127 |
| 103 | negative regulation of stress fiber assembly (GO:0051497) | 2.82366863 |
| 104 | protein activation cascade (GO:0072376) | 2.79801582 |
| 105 | extracellular matrix assembly (GO:0085029) | 2.76777166 |
| 106 | polyol transport (GO:0015791) | 2.74946440 |
| 107 | apoptotic cell clearance (GO:0043277) | 2.72520488 |
| 108 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.71686940 |
| 109 | membrane protein proteolysis (GO:0033619) | 2.70753889 |
| 110 | establishment of epithelial cell polarity (GO:0090162) | 2.69986855 |
| 111 | reactive oxygen species biosynthetic process (GO:1903409) | 2.67361913 |
| 112 | renal system process involved in regulation of blood volume (GO:0001977) | 2.65072250 |
| 113 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.63561394 |
| 114 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.60539276 |
| 115 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.59675118 |
| 116 | diol metabolic process (GO:0034311) | 2.58865368 |
| 117 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.57245152 |
| 118 | multicellular organismal water homeostasis (GO:0050891) | 2.56175102 |
| 119 | gas transport (GO:0015669) | 2.55365703 |
| 120 | midgut development (GO:0007494) | 2.55282588 |
| 121 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.55030933 |
| 122 | glomerular filtration (GO:0003094) | 2.55013026 |
| 123 | import into cell (GO:0098657) | 2.54772511 |
| 124 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.54739022 |
| 125 | regulation of interleukin-5 production (GO:0032674) | 2.53018539 |
| 126 | regulation of cholesterol storage (GO:0010885) | 2.52861137 |
| 127 | negative regulation of adherens junction organization (GO:1903392) | 2.52596657 |
| 128 | negative regulation of focal adhesion assembly (GO:0051895) | 2.52596657 |
| 129 | negative regulation of cell junction assembly (GO:1901889) | 2.52596657 |
| 130 | toxin transport (GO:1901998) | 2.52310062 |
| 131 | positive regulation of positive chemotaxis (GO:0050927) | 2.51817328 |
| 132 | positive regulation of phagocytosis (GO:0050766) | 2.51570740 |
| 133 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.51407583 |
| 134 | negative regulation of T cell proliferation (GO:0042130) | 2.50495938 |
| 135 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.50326889 |
| 136 | Leydig cell differentiation (GO:0033327) | 2.50222141 |
| 137 | establishment of endothelial barrier (GO:0061028) | 2.48473826 |
| 138 | angiotensin maturation (GO:0002003) | 2.48237103 |
| 139 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.47965180 |
| 140 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.47877227 |
| 141 | regulation of p38MAPK cascade (GO:1900744) | 2.47465407 |
| 142 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.47124253 |
| 143 | basement membrane organization (GO:0071711) | 2.47033588 |
| 144 | atrioventricular valve morphogenesis (GO:0003181) | 2.45729799 |
| 145 | T cell mediated immunity (GO:0002456) | 2.45048829 |
| 146 | fibroblast migration (GO:0010761) | 2.43916080 |
| 147 | intestinal epithelial cell development (GO:0060576) | 2.43716663 |
| 148 | cellular sodium ion homeostasis (GO:0006883) | 2.43063708 |
| 149 | positive regulation of chemokine secretion (GO:0090197) | 2.41897305 |
| 150 | regulation of positive chemotaxis (GO:0050926) | 2.40033542 |
| 151 | response to thyroid hormone (GO:0097066) | 2.40000799 |
| 152 | complement activation, alternative pathway (GO:0006957) | 2.39709184 |
| 153 | ethanol metabolic process (GO:0006067) | 2.37394719 |
| 154 | cell volume homeostasis (GO:0006884) | 2.37024795 |
| 155 | regulation of macrophage chemotaxis (GO:0010758) | 2.36478551 |
| 156 | icosanoid secretion (GO:0032309) | 2.36380417 |
| 157 | surfactant homeostasis (GO:0043129) | 18.1195726 |
| 158 | chemical homeostasis within a tissue (GO:0048875) | 14.4878660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.15825792 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.66387812 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.37873178 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.12515953 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.00959876 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.79656418 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79074187 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.74458543 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.53670230 |
| 10 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.51164944 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.49770804 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.41050143 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.31091077 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.17815647 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.05638482 |
| 16 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.04327053 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.03588836 |
| 18 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.97206165 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95024947 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94587828 |
| 21 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.81798511 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.81299719 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.81093263 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.77624434 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70605371 |
| 26 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69283490 |
| 27 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.63346156 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62929234 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62176196 |
| 30 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.59395001 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57600611 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55450419 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54970960 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.53369794 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.52611382 |
| 36 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.52611382 |
| 37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.52540767 |
| 38 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.51624585 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50715869 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.50392550 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50201796 |
| 42 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49452238 |
| 43 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.49437815 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.48188676 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47685977 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45466571 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.43725762 |
| 48 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.43518401 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43026108 |
| 50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.40504578 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40462197 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40330821 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37931644 |
| 54 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.37334071 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.36377257 |
| 56 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36015765 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35857994 |
| 58 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34642195 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33877084 |
| 60 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.32164687 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29747936 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29588130 |
| 63 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29228576 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28266403 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24327262 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24188420 |
| 67 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22341855 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21936855 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21033452 |
| 70 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18605490 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18472051 |
| 72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17383259 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17344074 |
| 74 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17114725 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.14250800 |
| 76 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13933523 |
| 77 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12299803 |
| 78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12042380 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12042380 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11588050 |
| 81 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11510164 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09407292 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09253136 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09136826 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09130754 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08682153 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.08499845 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08212895 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07713079 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07697056 |
| 91 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06964323 |
| 92 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06028968 |
| 93 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04350073 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04060592 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03818423 |
| 96 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02022243 |
| 97 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01637928 |
| 98 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.01398702 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00930402 |
| 100 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99945712 |
| 101 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99856163 |
| 102 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99252348 |
| 103 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99121223 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98974486 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98824086 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98617717 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95036864 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93395210 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92996281 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92917529 |
| 111 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91926556 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91717475 |
| 113 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91582641 |
| 114 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90959258 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90096352 |
| 116 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89542778 |
| 117 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89248681 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89215088 |
| 119 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89215088 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88866301 |
| 121 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.88554205 |
| 122 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88343487 |
| 123 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86704419 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86689978 |
| 125 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.86305697 |
| 126 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86040869 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85644623 |
| 128 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.85573803 |
| 129 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85288180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004782_abnormal_surfactant_physiolog | 7.83898881 |
| 2 | MP0001958_emphysema | 6.83717716 |
| 3 | MP0008995_early_reproductive_senescence | 4.73896826 |
| 4 | MP0010368_abnormal_lymphatic_system | 4.13851353 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 3.81234981 |
| 6 | MP0005083_abnormal_biliary_tract | 3.77219244 |
| 7 | MP0001542_abnormal_bone_strength | 3.44322058 |
| 8 | MP0008004_abnormal_stomach_pH | 3.37352639 |
| 9 | MP0003724_increased_susceptibility_to | 3.15319146 |
| 10 | MP0001879_abnormal_lymphatic_vessel | 3.07272113 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 3.04177387 |
| 12 | MP0001177_atelectasis | 2.84129426 |
| 13 | MP0002295_abnormal_pulmonary_circulatio | 2.61576644 |
| 14 | MP0002132_abnormal_respiratory_system | 2.59168194 |
| 15 | * MP0005388_respiratory_system_phenotype | 2.57090858 |
| 16 | * MP0002133_abnormal_respiratory_system | 2.57090858 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.52894367 |
| 18 | MP0000537_abnormal_urethra_morphology | 2.23978421 |
| 19 | MP0004272_abnormal_basement_membrane | 1.96288152 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.94225838 |
| 21 | MP0000566_synostosis | 1.83797237 |
| 22 | MP0002277_abnormal_respiratory_mucosa | 1.80664111 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 1.73083199 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.65908297 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.62794279 |
| 26 | MP0003690_abnormal_glial_cell | 1.58457986 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.54454409 |
| 28 | MP0001440_abnormal_grooming_behavior | 1.52158382 |
| 29 | MP0002998_abnormal_bone_remodeling | 1.45993772 |
| 30 | MP0000343_altered_response_to | 1.39348060 |
| 31 | * MP0001175_abnormal_lung_morphology | 1.34654161 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.30533029 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.24094674 |
| 34 | MP0005275_abnormal_skin_tensile | 1.22028005 |
| 35 | MP0005164_abnormal_response_to | 1.18753796 |
| 36 | MP0004883_abnormal_blood_vessel | 1.17907769 |
| 37 | MP0000767_abnormal_smooth_muscle | 1.17804137 |
| 38 | MP0000249_abnormal_blood_vessel | 1.17008025 |
| 39 | MP0005595_abnormal_vascular_smooth | 1.15942655 |
| 40 | MP0001851_eye_inflammation | 1.15676956 |
| 41 | MP0003115_abnormal_respiratory_system | 1.14649279 |
| 42 | MP0005408_hypopigmentation | 1.14404354 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.14129384 |
| 44 | MP0002139_abnormal_hepatobiliary_system | 1.14014577 |
| 45 | MP0003303_peritoneal_inflammation | 1.12593659 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.11350201 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.11350201 |
| 48 | MP0000534_abnormal_ureter_morphology | 1.08272515 |
| 49 | MP0003786_premature_aging | 1.07573763 |
| 50 | MP0003279_aneurysm | 1.06752038 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.05745391 |
| 52 | MP0006138_congestive_heart_failure | 1.00897150 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.00421295 |
| 54 | MP0003091_abnormal_cell_migration | 1.00062175 |
| 55 | MP0006054_spinal_hemorrhage | 0.98708864 |
| 56 | MP0005166_decreased_susceptibility_to | 0.95259188 |
| 57 | MP0005023_abnormal_wound_healing | 0.93302542 |
| 58 | MP0002419_abnormal_innate_immunity | 0.92212314 |
| 59 | MP0008438_abnormal_cutaneous_collagen | 0.90497629 |
| 60 | MP0003300_gastrointestinal_ulcer | 0.88957942 |
| 61 | MP0010678_abnormal_skin_adnexa | 0.87626489 |
| 62 | MP0005085_abnormal_gallbladder_physiolo | 0.87231633 |
| 63 | MP0005503_abnormal_tendon_morphology | 0.86837829 |
| 64 | MP0000013_abnormal_adipose_tissue | 0.86590096 |
| 65 | MP0002166_altered_tumor_susceptibility | 0.84919074 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.84134886 |
| 67 | MP0009840_abnormal_foam_cell | 0.83122146 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.82633144 |
| 69 | MP0003075_altered_response_to | 0.81247718 |
| 70 | MP0000462_abnormal_digestive_system | 0.81177166 |
| 71 | MP0002332_abnormal_exercise_endurance | 0.80102233 |
| 72 | MP0002909_abnormal_adrenal_gland | 0.79551432 |
| 73 | MP0003828_pulmonary_edema | 0.78207110 |
| 74 | MP0002733_abnormal_thermal_nociception | 0.77914675 |
| 75 | MP0010329_abnormal_lipoprotein_level | 0.77833405 |
| 76 | MP0002796_impaired_skin_barrier | 0.77542524 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 0.77056213 |
| 78 | MP0004947_skin_inflammation | 0.76729103 |
| 79 | MP0002098_abnormal_vibrissa_morphology | 0.76681072 |
| 80 | MP0000604_amyloidosis | 0.76353427 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.75890646 |
| 82 | MP0003448_altered_tumor_morphology | 0.75639567 |
| 83 | MP0002128_abnormal_blood_circulation | 0.73877933 |
| 84 | MP0001533_abnormal_skeleton_physiology | 0.72544937 |
| 85 | MP0002925_abnormal_cardiovascular_devel | 0.70997911 |
| 86 | MP0006082_CNS_inflammation | 0.70734440 |
| 87 | * MP0005025_abnormal_response_to | 0.68209060 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.68060642 |
| 89 | MP0002168_other_aberrant_phenotype | 0.67273570 |
| 90 | MP0001666_abnormal_nutrient_absorption | 0.66808590 |
| 91 | * MP0001943_abnormal_respiration | 0.66654007 |
| 92 | MP0002282_abnormal_trachea_morphology | 0.66541133 |
| 93 | MP0005165_increased_susceptibility_to | 0.65106350 |
| 94 | MP0001664_abnormal_digestion | 0.64776527 |
| 95 | MP0004484_altered_response_of | 0.64631005 |
| 96 | MP0004084_abnormal_cardiac_muscle | 0.64620998 |
| 97 | MP0001614_abnormal_blood_vessel | 0.64589740 |
| 98 | MP0009764_decreased_sensitivity_to | 0.63314101 |
| 99 | MP0005387_immune_system_phenotype | 0.63174005 |
| 100 | MP0001790_abnormal_immune_system | 0.63174005 |
| 101 | MP0002009_preneoplasia | 0.62791427 |
| 102 | MP0001544_abnormal_cardiovascular_syste | 0.62247656 |
| 103 | MP0005385_cardiovascular_system_phenoty | 0.62247656 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.61804631 |
| 105 | MP0000685_abnormal_immune_system | 0.61330750 |
| 106 | * MP0002118_abnormal_lipid_homeostasis | 0.60492151 |
| 107 | MP0004085_abnormal_heartbeat | 0.60183300 |
| 108 | MP0004510_myositis | 0.59446748 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.59051653 |
| 110 | MP0000383_abnormal_hair_follicle | 0.58633845 |
| 111 | MP0001853_heart_inflammation | 0.58180595 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.57901152 |
| 113 | MP0008775_abnormal_heart_ventricle | 0.57317879 |
| 114 | MP0001661_extended_life_span | 0.56993176 |
| 115 | MP0005332_abnormal_amino_acid | 0.56284910 |
| 116 | MP0003045_fibrosis | 0.55948486 |
| 117 | MP0005647_abnormal_sex_gland | 0.53265559 |
| 118 | MP0003795_abnormal_bone_structure | 0.52550368 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.52307870 |
| 120 | MP0001346_abnormal_lacrimal_gland | 0.52117150 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.52029007 |
| 122 | MP0002135_abnormal_kidney_morphology | 0.51185263 |
| 123 | MP0001756_abnormal_urination | 0.50284461 |
| 124 | MP0000920_abnormal_myelination | 0.49681566 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.49423066 |
| 126 | MP0003329_amyloid_beta_deposits | 0.48197495 |
| 127 | MP0002234_abnormal_pharynx_morphology | 0.47664081 |
| 128 | * MP0002405_respiratory_system_inflammati | 0.47256230 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.47198428 |
| 130 | MP0004130_abnormal_muscle_cell | 0.46926118 |
| 131 | MP0000627_abnormal_mammary_gland | 0.46761954 |
| 132 | MP0000681_abnormal_thyroid_gland | 0.46712253 |
| 133 | MP0003436_decreased_susceptibility_to | 0.46588292 |
| 134 | MP0004885_abnormal_endolymph | 0.45776996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 7.03154801 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 6.87795809 |
| 3 | Tubulointerstitial fibrosis (HP:0005576) | 6.56391273 |
| 4 | Chronic bronchitis (HP:0004469) | 6.14687740 |
| 5 | Tachypnea (HP:0002789) | 6.05988950 |
| 6 | Alveolar cell carcinoma (HP:0006519) | 5.93377262 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.53542453 |
| 8 | Polycythemia (HP:0001901) | 5.53242218 |
| 9 | Neoplasm of the tracheobronchial system (HP:0100552) | 5.53133115 |
| 10 | Renal salt wasting (HP:0000127) | 5.50709160 |
| 11 | Respiratory distress (HP:0002098) | 5.39350067 |
| 12 | Hematochezia (HP:0002573) | 5.00710038 |
| 13 | Exertional dyspnea (HP:0002875) | 4.96028529 |
| 14 | Glomerulonephritis (HP:0000099) | 4.64504537 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 4.54662654 |
| 16 | Gout (HP:0001997) | 4.41038432 |
| 17 | Spontaneous hematomas (HP:0007420) | 4.39695289 |
| 18 | Hyperkalemia (HP:0002153) | 4.22708096 |
| 19 | Neurofibrillary tangles (HP:0002185) | 4.13890810 |
| 20 | Abnormality of complement system (HP:0005339) | 3.79714392 |
| 21 | Visceral angiomatosis (HP:0100761) | 3.77217154 |
| 22 | Tubulointerstitial abnormality (HP:0001969) | 3.76141580 |
| 23 | Onycholysis (HP:0001806) | 3.57902459 |
| 24 | Pulmonary fibrosis (HP:0002206) | 3.52337781 |
| 25 | Hemangiomatosis (HP:0007461) | 3.51088576 |
| 26 | Ulnar bowing (HP:0003031) | 3.44193831 |
| 27 | Hypergammaglobulinemia (HP:0010702) | 3.31997634 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 3.31960185 |
| 29 | Esophageal varix (HP:0002040) | 3.25632747 |
| 30 | Hyperaldosteronism (HP:0000859) | 3.21516338 |
| 31 | Bronchitis (HP:0012387) | 3.11754485 |
| 32 | Tubulointerstitial nephritis (HP:0001970) | 3.11358178 |
| 33 | Hypotension (HP:0002615) | 3.06723656 |
| 34 | Broad metatarsal (HP:0001783) | 3.05430737 |
| 35 | Chronic otitis media (HP:0000389) | 2.97762251 |
| 36 | Neoplasm of the lung (HP:0100526) | 2.96508371 |
| 37 | Abnormality of chloride homeostasis (HP:0011422) | 2.96148791 |
| 38 | Long toe (HP:0010511) | 2.92492755 |
| 39 | Conjunctival telangiectasia (HP:0000524) | 2.89337321 |
| 40 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.88751822 |
| 41 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.85262288 |
| 42 | Single umbilical artery (HP:0001195) | 2.85262288 |
| 43 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.85262288 |
| 44 | Abnormality of renin-angiotensin system (HP:0000847) | 2.81274789 |
| 45 | Decreased circulating renin level (HP:0003351) | 2.78405273 |
| 46 | Potter facies (HP:0002009) | 2.69626030 |
| 47 | Facial shape deformation (HP:0011334) | 2.69626030 |
| 48 | Supranuclear gaze palsy (HP:0000605) | 2.64245667 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.63382478 |
| 50 | Osteolytic defects of the hand bones (HP:0009699) | 2.63382478 |
| 51 | Cerebral hemorrhage (HP:0001342) | 2.63048287 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.62348908 |
| 53 | Neoplasm of the respiratory system (HP:0100606) | 2.59185491 |
| 54 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.56325694 |
| 55 | Pulmonary hypertension (HP:0002092) | 2.51762422 |
| 56 | Growth hormone excess (HP:0000845) | 2.50090536 |
| 57 | Loss of speech (HP:0002371) | 2.45028071 |
| 58 | Vascular tortuosity (HP:0004948) | 2.44993270 |
| 59 | Bronchomalacia (HP:0002780) | 2.43970111 |
| 60 | Deep venous thrombosis (HP:0002625) | 2.41905549 |
| 61 | Ulnar claw (HP:0001178) | 2.41405081 |
| 62 | Neonatal respiratory distress (HP:0002643) | 2.38993810 |
| 63 | Hyponatremia (HP:0002902) | 2.34884318 |
| 64 | Prostate neoplasm (HP:0100787) | 2.34331129 |
| 65 | Bowing of the arm (HP:0006488) | 2.33959315 |
| 66 | Bowed forearm bones (HP:0003956) | 2.33959315 |
| 67 | Tubular atrophy (HP:0000092) | 2.31458766 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26473969 |
| 69 | Stomach cancer (HP:0012126) | 2.24753993 |
| 70 | Hypokalemic alkalosis (HP:0001949) | 2.22441418 |
| 71 | Thyroid-stimulating hormone excess (HP:0002925) | 2.19151622 |
| 72 | Glucose intolerance (HP:0000833) | 2.16808044 |
| 73 | Arterial tortuosity (HP:0005116) | 2.15800632 |
| 74 | Cavernous hemangioma (HP:0001048) | 2.10197647 |
| 75 | Increased CSF protein (HP:0002922) | 2.09514254 |
| 76 | Fragile nails (HP:0001808) | 2.07799754 |
| 77 | Eczematoid dermatitis (HP:0000976) | 2.04468688 |
| 78 | Microcytic anemia (HP:0001935) | 2.04383076 |
| 79 | Pulmonary artery stenosis (HP:0004415) | 2.03818819 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 13.6159791 |
| 81 | Glomerulosclerosis (HP:0000096) | 1.98932087 |
| 82 | Subacute progressive viral hepatitis (HP:0006572) | 1.98686478 |
| 83 | Rapidly progressive (HP:0003678) | 1.97630629 |
| 84 | Restrictive lung disease (HP:0002091) | 1.97088977 |
| 85 | Striae distensae (HP:0001065) | 1.96891620 |
| 86 | Shallow orbits (HP:0000586) | 1.96503690 |
| 87 | Distal lower limb muscle weakness (HP:0009053) | 1.96397623 |
| 88 | Complement deficiency (HP:0004431) | 1.95681846 |
| 89 | Atrophic scars (HP:0001075) | 1.95548712 |
| 90 | Stenosis of the external auditory canal (HP:0000402) | 1.94933894 |
| 91 | Bronchiectasis (HP:0002110) | 1.94459505 |
| 92 | Rectal prolapse (HP:0002035) | 1.94328916 |
| 93 | Annular pancreas (HP:0001734) | 1.93662845 |
| 94 | Hyperpituitarism (HP:0010514) | 1.92841121 |
| 95 | Abnormality of macrophages (HP:0004311) | 1.91469969 |
| 96 | Intestinal atresia (HP:0011100) | 1.89977316 |
| 97 | Synostosis involving the elbow (HP:0003938) | 1.89579726 |
| 98 | Humeroradial synostosis (HP:0003041) | 1.89579726 |
| 99 | Recurrent abscess formation (HP:0002722) | 1.89427355 |
| 100 | Megalencephaly (HP:0001355) | 1.89200815 |
| 101 | Abnormality of sodium homeostasis (HP:0010931) | 1.88454282 |
| 102 | Adrenal overactivity (HP:0002717) | 1.87473953 |
| 103 | Increased purine levels (HP:0004368) | 1.86209310 |
| 104 | Hyperuricemia (HP:0002149) | 1.86209310 |
| 105 | Milia (HP:0001056) | 1.84022672 |
| 106 | Shawl scrotum (HP:0000049) | 1.83451735 |
| 107 | Skin nodule (HP:0200036) | 1.82876928 |
| 108 | Aplasia of the phalanges of the hand (HP:0009802) | 1.82789458 |
| 109 | Aplasia involving bones of the extremities (HP:0009825) | 1.82789458 |
| 110 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.82789458 |
| 111 | Joint swelling (HP:0001386) | 1.80592272 |
| 112 | Camptodactyly of toe (HP:0001836) | 1.80185944 |
| 113 | Mucosal telangiectasiae (HP:0100579) | 1.77398927 |
| 114 | Abnormality of the pulmonary veins (HP:0011718) | 1.77105913 |
| 115 | Pustule (HP:0200039) | 1.75705695 |
| 116 | Partial duplication of thumb phalanx (HP:0009944) | 1.74837798 |
| 117 | Thickened helices (HP:0000391) | 1.72675300 |
| 118 | Nasal polyposis (HP:0100582) | 1.71106622 |
| 119 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.63895214 |
| 120 | Mucopolysacchariduria (HP:0008155) | 1.63895214 |
| 121 | Turricephaly (HP:0000262) | 1.63391927 |
| 122 | Plantar hyperkeratosis (HP:0007556) | 1.62183891 |
| 123 | Split foot (HP:0001839) | 1.60691750 |
| 124 | Wormian bones (HP:0002645) | 1.58727018 |
| 125 | Myocardial infarction (HP:0001658) | 1.58310132 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.57665928 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.57665928 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.57665928 |
| 129 | Aortic aneurysm (HP:0004942) | 1.57285090 |
| 130 | Abnormality of purine metabolism (HP:0004352) | 1.56239531 |
| 131 | Nephritis (HP:0000123) | 1.55642752 |
| 132 | Abnormality of the umbilical cord (HP:0010881) | 1.55180607 |
| 133 | Abnormal glucose tolerance (HP:0001952) | 1.55067032 |
| 134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.52951984 |
| 135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.52951984 |
| 136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.52951984 |
| 137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.50903921 |
| 138 | Joint contractures involving the joints of the feet (HP:0100492) | 1.50061297 |
| 139 | Flexion contracture of toe (HP:0005830) | 1.50061297 |
| 140 | Aneurysm (HP:0002617) | 1.48628404 |
| 141 | Seborrheic dermatitis (HP:0001051) | 1.48228906 |
| 142 | Abnormality of the periventricular white matter (HP:0002518) | 1.46211930 |
| 143 | Aortic dissection (HP:0002647) | 1.45300532 |
| 144 | Abnormality of the prostate (HP:0008775) | 1.43746264 |
| 145 | Onion bulb formation (HP:0003383) | 1.43186941 |
| 146 | Purpura (HP:0000979) | 1.43040323 |
| 147 | Mitral valve prolapse (HP:0001634) | 1.42518055 |
| 148 | Increased connective tissue (HP:0009025) | 1.42432032 |
| 149 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.39920356 |
| 150 | Mitral stenosis (HP:0001718) | 1.36000935 |
| 151 | Absent hand (HP:0004050) | 1.34769856 |
| 152 | Atrioventricular block (HP:0001678) | 1.34001891 |
| 153 | Adactyly (HP:0009776) | 1.33779384 |
| 154 | Difficulty walking (HP:0002355) | 1.33214044 |
| 155 | Increased cerebral lipofuscin (HP:0011813) | 1.31629287 |
| 156 | Gingivitis (HP:0000230) | 1.29838894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.35962098 |
| 2 | FGFR2 | 4.43785026 |
| 3 | TGFBR2 | 3.94860632 |
| 4 | LRRK2 | 3.28026636 |
| 5 | STK24 | 3.15218692 |
| 6 | PAK4 | 2.64198805 |
| 7 | EPHB2 | 2.51843913 |
| 8 | ZAP70 | 2.51679188 |
| 9 | LMTK2 | 2.37075954 |
| 10 | TRIB3 | 2.36624320 |
| 11 | EPHB1 | 2.28440561 |
| 12 | DAPK2 | 2.27013172 |
| 13 | GRK1 | 2.08731427 |
| 14 | RIPK1 | 2.04821251 |
| 15 | FGFR4 | 1.95079915 |
| 16 | PRPF4B | 1.83247728 |
| 17 | MST4 | 1.82596888 |
| 18 | FER | 1.80919058 |
| 19 | CDC42BPA | 1.80589925 |
| 20 | ILK | 1.79961914 |
| 21 | NLK | 1.79146054 |
| 22 | PDGFRB | 1.78796639 |
| 23 | STK10 | 1.75121126 |
| 24 | MAP3K14 | 1.69697302 |
| 25 | MAP3K3 | 1.66260594 |
| 26 | ERN1 | 1.58770053 |
| 27 | EPHA2 | 1.54609606 |
| 28 | MYLK | 1.53083251 |
| 29 | MAP3K2 | 1.51299389 |
| 30 | MAP3K6 | 1.50899686 |
| 31 | STK38L | 1.50149876 |
| 32 | LATS2 | 1.44749588 |
| 33 | MST1R | 1.43930853 |
| 34 | IRAK1 | 1.42333800 |
| 35 | TESK1 | 1.41429540 |
| 36 | MAP3K13 | 1.37230482 |
| 37 | PTK6 | 1.36080466 |
| 38 | PDGFRA | 1.26859304 |
| 39 | TGFBR1 | 1.19052963 |
| 40 | KSR2 | 1.17578265 |
| 41 | KDR | 1.14778885 |
| 42 | YES1 | 1.14623425 |
| 43 | TRPM7 | 1.13864491 |
| 44 | MAPK15 | 1.11207173 |
| 45 | EPHA3 | 1.09603978 |
| 46 | FGFR3 | 1.08351721 |
| 47 | CSK | 1.07168009 |
| 48 | MET | 1.07159288 |
| 49 | MAPK7 | 1.05193473 |
| 50 | AKT3 | 1.02786569 |
| 51 | CAMK1D | 0.98497676 |
| 52 | MAPK12 | 0.94783753 |
| 53 | GSK3A | 0.93548752 |
| 54 | LIMK1 | 0.91233486 |
| 55 | CDK6 | 0.90865135 |
| 56 | SGK2 | 0.88308950 |
| 57 | TAOK3 | 0.88048830 |
| 58 | PTK2B | 0.84517094 |
| 59 | PRKD1 | 0.83173922 |
| 60 | PDK2 | 0.82233531 |
| 61 | EGFR | 0.81063551 |
| 62 | MAP3K9 | 0.78831456 |
| 63 | KIT | 0.78599122 |
| 64 | MAP2K3 | 0.77991039 |
| 65 | SIK1 | 0.73710476 |
| 66 | MAP3K12 | 0.71733012 |
| 67 | LATS1 | 0.70457220 |
| 68 | PTK2 | 0.68326887 |
| 69 | MAP3K7 | 0.67469674 |
| 70 | ERBB4 | 0.67369179 |
| 71 | TTN | 0.66556560 |
| 72 | DDR2 | 0.65953434 |
| 73 | SGK223 | 0.61534006 |
| 74 | SGK494 | 0.61534006 |
| 75 | NEK9 | 0.61082688 |
| 76 | NTRK1 | 0.60432120 |
| 77 | PRKG2 | 0.58532383 |
| 78 | PDPK1 | 0.58229611 |
| 79 | JAK1 | 0.58135265 |
| 80 | TYK2 | 0.57748264 |
| 81 | PKN2 | 0.56378161 |
| 82 | NTRK3 | 0.56353133 |
| 83 | DAPK1 | 0.56218206 |
| 84 | DAPK3 | 0.55523053 |
| 85 | MAP3K1 | 0.55315666 |
| 86 | NEK6 | 0.54858850 |
| 87 | MATK | 0.53672855 |
| 88 | PRKCH | 0.51888944 |
| 89 | FGFR1 | 0.51546481 |
| 90 | MAPKAPK2 | 0.51434840 |
| 91 | MAP2K2 | 0.51388852 |
| 92 | STK38 | 0.51059249 |
| 93 | PRKCQ | 0.50712319 |
| 94 | INSR | 0.50700735 |
| 95 | RPS6KL1 | 0.49605549 |
| 96 | RPS6KC1 | 0.49605549 |
| 97 | CAMK1G | 0.47669114 |
| 98 | MTOR | 0.47281640 |
| 99 | GRK7 | 0.45615785 |
| 100 | ERBB3 | 0.45097677 |
| 101 | MAP2K1 | 0.43027080 |
| 102 | TBK1 | 0.41690158 |
| 103 | ROCK2 | 0.41683789 |
| 104 | BLK | 0.40535667 |
| 105 | MAPK3 | 0.40477483 |
| 106 | BMX | 0.40270192 |
| 107 | DMPK | 0.39870972 |
| 108 | MAP4K1 | 0.39830069 |
| 109 | PDK1 | 0.39424713 |
| 110 | TEC | 0.39157382 |
| 111 | ERBB2 | 0.38464562 |
| 112 | MARK2 | 0.38260719 |
| 113 | RET | 0.38106588 |
| 114 | MAPK4 | 0.37276351 |
| 115 | GRK5 | 0.36931603 |
| 116 | MELK | 0.36877871 |
| 117 | MOS | 0.36851005 |
| 118 | FGR | 0.36303453 |
| 119 | ROCK1 | 0.36013800 |
| 120 | RPS6KA6 | 0.35691773 |
| 121 | BCR | 0.35629587 |
| 122 | ABL1 | 0.33531760 |
| 123 | RPS6KA4 | 0.33188317 |
| 124 | MAPK1 | 0.33036658 |
| 125 | FES | 0.32963223 |
| 126 | HIPK2 | 0.32823989 |
| 127 | RPS6KA5 | 0.32117223 |
| 128 | PRKCE | 0.29809766 |
| 129 | IGF1R | 0.29644380 |
| 130 | FYN | 0.29145856 |
| 131 | TYRO3 | 0.29069127 |
| 132 | JAK2 | 0.28604173 |
| 133 | SGK3 | 0.28439625 |
| 134 | WNK4 | 0.27264031 |
| 135 | IKBKE | 0.27069051 |
| 136 | SRC | 0.25508641 |
| 137 | PRKCD | 0.25068704 |
| 138 | MAP3K11 | 0.22609739 |
| 139 | RPS6KA2 | 0.22037574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.27777859 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 2.86974872 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.63960671 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.54592421 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.29614107 |
| 6 | Adherens junction_Homo sapiens_hsa04520 | 2.19917920 |
| 7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.12711818 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95324703 |
| 9 | Tight junction_Homo sapiens_hsa04530 | 1.89543928 |
| 10 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.86112439 |
| 11 | Asthma_Homo sapiens_hsa05310 | 1.85510405 |
| 12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.81900342 |
| 13 | Focal adhesion_Homo sapiens_hsa04510 | 1.74349122 |
| 14 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.67081223 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59394993 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.56288390 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.55946558 |
| 18 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.55191809 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54601359 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51777474 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48356617 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.47475967 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.40655491 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.38097818 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.37030226 |
| 26 | * Phagosome_Homo sapiens_hsa04145 | 1.36525461 |
| 27 | Bladder cancer_Homo sapiens_hsa05219 | 1.35919812 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34456755 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33240752 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29503763 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26830514 |
| 32 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.26705877 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26565394 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.25980208 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22027874 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21605568 |
| 37 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.20736758 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.20606538 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.17986168 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14778463 |
| 41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.14637411 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12472258 |
| 43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.11947647 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09894222 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07517729 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06187819 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05983029 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05754471 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.02938198 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 1.02593777 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 1.02097752 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00472856 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99438264 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96849329 |
| 55 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.95007650 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92651088 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92490864 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.91886915 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89807239 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89382840 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89192951 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85800207 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85305170 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85154259 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.84486711 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.84210889 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83459538 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82810023 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80352983 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 0.79434736 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.77221836 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77013395 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76436149 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.75277408 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75053622 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74415624 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73900679 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73509231 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.73177728 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72567591 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72565687 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72463386 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72132805 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.70826949 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70611079 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68630732 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68173856 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66588167 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66261136 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65786950 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65467887 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64573772 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63737479 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62202969 |
| 95 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.61558126 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58363590 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57692737 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.57133319 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56030633 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55960263 |
| 101 | * Pertussis_Homo sapiens_hsa05133 | 0.55637930 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.54908161 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53847643 |
| 104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.53735140 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53553790 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51837819 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51218418 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50873897 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50053720 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.49952794 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49696122 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48355717 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48141922 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47476508 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47415356 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46945544 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46917587 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45578779 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.43081241 |
| 120 | Long-term depression_Homo sapiens_hsa04730 | 0.42788638 |
| 121 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42763127 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.42105764 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.41831759 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41536482 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41468007 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40568917 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40297804 |
| 128 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37714589 |
| 129 | Melanoma_Homo sapiens_hsa05218 | 0.37616769 |
| 130 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37436184 |
| 131 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36985502 |
| 132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36963821 |
| 133 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36562299 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35892166 |

